{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:19:02Z","timestamp":1787660342037,"version":"build-2736575974"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/03\/X\/HS6\/01173"],"award-info":[{"award-number":["2019\/03\/X\/HS6\/01173"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neurofibromatosis type 1 (NF1) is a rare autosomal dominant disorder that presents complex physical, emotional, and social challenges. Despite clear diagnostic criteria, NF1 is often diagnosed late due to vague early symptoms, everyday or non-medical interpretations of early signs, and limited access to specialists and genetic testing. This study explores how individuals with NF1 experience the diagnostic process in this context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ninety-three adults with medically confirmed NF1 participated in in-depth interviews conducted between August 1 and 31 December 2020. Data were analyzed using reflexive thematic analysis, following Braun and Clarke\u2019s six-phase framework to explore patterns in participants\u2019 experiences and meaning-making related to diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The diagnostic pathway for NF1 was often prolonged, fragmented, and emotionally taxing. Delays frequently stemmed from the normalization of early signs (e.g., caf\u00e9-au-lait macules or subcutaneous nodules) by both families and physicians. Many participants received their diagnosis incidentally, or only after persistent self-advocacy, parental initiative, or the diagnosis of their child. While some family members, particularly mothers, played an active diagnostic role, others responded with denial, minimization, or reluctance to discuss symptoms, which in turn prolonged the search for answers. Structural factors, such as limited NF1-specific familiarity among primary care providers, constrained referral pathways, and regional disparities, further complicated the diagnostic odyssey. The unpredictability and burden of diagnosis often led to frustration and emotional fatigue, particularly among those who lacked a family history of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study emphasizes the need for earlier NF1 recognition through enhanced clinician awareness, better diagnostic coordination, and access to genetic and psychosocial support. It also highlights the role of patient agency and the emotional cost of delayed diagnosis in rare diseases. These findings point to several actionable priorities, including the need to strengthen NF1-specific training for primary care physicians, implement clearer referral pathways, and expand access to genetic counselling and psychosocial support.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2025.1713304","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T22:10:14Z","timestamp":1767737414000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["(Not) \u201cjust your nature\u201d. Diagnostic journeys of adults with neurofibromatosis type 1 in Poland"],"prefix":"10.3389","volume":"16","author":[{"given":"Katarzyna","family":"Kowal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Domaradzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"B1","volume-title":"Living with genetic disorder. The impact of neurofibromatosis 1","author":"Ablon","year":"1999"},{"key":"B2","doi-asserted-by":"publisher","first-page":"dmm049362","DOI":"10.1242\/dmm.049362","article-title":"RAS and beyond: the many faces of the neurofibromatosis type 1 protein","volume":"15","author":"Anastasaki","year":"2022","journal-title":"Dis. Model Mech."},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1172-8-22","article-title":"Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support","volume":"8","author":"Anderson","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"100167","DOI":"10.1016\/j.ssmqr.2022.100167","article-title":"Long covid and medical gaslighting: Dismissal, delayed diagnosis, and deferred treatment","volume":"2","author":"Au","year":"2022","journal-title":"SSM Qual. Res. Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/jmd2.12403","article-title":"Patient and family experiences of lysosomal storage diseases in Canada: a qualitative interview study","volume":"65","author":"Awada","year":"2023","journal-title":"JIMD Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13023-022-02358-x","article-title":"The diagnostic odyssey: insights from parents of children living with an undiagnosed condition","volume":"17","author":"Bauskis","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1136\/medethics-2020-106558","article-title":"Need for patient-developed concepts of empowerment to rectify epistemic injustice and advance person-centred care","volume":"47","author":"Bogaert","year":"2021","journal-title":"J. Med. Ethics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","article-title":"Reflecting on reflexive thematic analysis","volume":"11","author":"Braun","year":"2019","journal-title":"Qual. Res. Sport, Exerc. Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","article-title":"One size fits all? What counts as quality practice in (reflexive) thematic analysis?","volume":"18","author":"Braun","year":"","journal-title":"Qual. Res. Psychol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/2159676X.2019.1704846","article-title":"To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales","volume":"13","author":"Braun","year":"","journal-title":"Qual. Res. Sport, Exerc. Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/26895269.2022.2129597","article-title":"Toward good practice in thematic analysis: avoiding common problems and be(com)ing a knowing researcher","volume":"24","author":"Braun","year":"2023","journal-title":"Int. J. Transgender Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/02692163241234800","article-title":"Supporting best practice in reflexive thematic analysis reporting in palliative medicine: a review of published research and introduction to the reflexive thematic Analysis Reporting guidelines (RTARG)","volume":"38","author":"Braun","year":"2024","journal-title":"Palliat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.healthpol.2012.02.018","article-title":"How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient-physician interaction","volume":"105","author":"Budych","year":"2012","journal-title":"Health Policy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s004310050644","article-title":"Diagnostic delay in neurofibromatosis type 1","volume":"156","author":"Cnossen","year":"1997","journal-title":"Eur. J. Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10897-015-9829-5","article-title":"The impact of neurofibromatosis type 1 on the health and wellbeing of Australian adults","volume":"24","author":"Crawford","year":"2015","journal-title":"J. Genet. Couns."},{"key":"B16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/cge.12627","article-title":"Uptake of health monitoring and disease self-management in Australian adults with neurofibromatosis type 1: strategies to improve care","volume":"89","author":"Crawford","year":"2016","journal-title":"Clin. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/cch.12628","article-title":"\u201cit is like a jungle gym, and everything is under construction\u201d: the parent\u2019s perspective of caring for a child with a rare disease","volume":"45","author":"Currie","year":"","journal-title":"Child. Care Health Dev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/hex.12958","article-title":"\u2018It would be much easier if we were just quiet and disappeared\u2019: parents silenced in the experience of caring for children with rare diseases","volume":"22","author":"Currie","year":"","journal-title":"Health Expect."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1725362","DOI":"10.1080\/17482631.2020.1725362","article-title":"Social isolation and exclusion: the parents\u2019 experience of caring for children with rare neurodevelopmental disorders","volume":"15","author":"Currie","year":"","journal-title":"Int. J. Qual. Stud. Health Well-being"},{"key":"B20","doi-asserted-by":"publisher","first-page":"813519","DOI":"10.3389\/fpsyt.2022.813519","article-title":"How do children of parents with mental illness experience stigma? A systematic mixed studies review","volume":"13","author":"Dobener","year":"2022","journal-title":"Front. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"14016","DOI":"10.1038\/s41598-024-63962-4","article-title":"Invisible patients in rare diseases: parental experiences with the healthcare and social services for children with rare diseases. A mixed method study","volume":"14","author":"Domaradzki","year":"2024","journal-title":"Sci. Rep."},{"key":"B22","first-page":"165","article-title":"Normalisation of unexplained symptoms by general practitioners: a functional typology","volume":"54","author":"Dowrick","year":"2004","journal-title":"Br. J. Gen. Pract."},{"key":"B23","doi-asserted-by":"publisher","first-page":"rkz022","DOI":"10.1093\/rap\/rkz022","article-title":"Diagnosis and initial management in psoriatic arthritis: a qualitative study with patients","volume":"3","author":"Dures","year":"2019","journal-title":"Rheumatol. Adv. Pract."},{"key":"B24","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1093\/bjd\/ljae090.039","article-title":"P012 A delayed diagnosis of neurofibromatosis type 1 during pregnancy","volume":"191","author":"Dyer","year":"2024","journal-title":"Br. J. Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF00114808","article-title":"Disease and illness. Distinctions between professional and popular ideas of sickness","volume":"1","author":"Eisenberg","year":"1977","journal-title":"Cult. Med. Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s12687-025-00811-5","article-title":"Enhancing care coordination for neurofibromatosis type 1 in primary care: insights and applications for rare diseases","volume":"16","author":"Evans","year":"2025","journal-title":"J. Community Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41431-024-01604-z","article-title":"Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a rare barometer retrospective patient survey","volume":"32","author":"Faye","year":"2024","journal-title":"Eur. J. Hum. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5582\/irdr.2022.01079","article-title":"Knowledge level of medical students and physicians about rare diseases in Lima, Peru","volume":"11","author":"Flores","year":"2022","journal-title":"Intractable Rare Dis. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/02813438409017707","article-title":"Lay concepts and strategies for handling symptoms of disease. A sample of adult men and women experiencing back pain symptoms","volume":"2","author":"Gannik","year":"1984","journal-title":"Scand. J. Prim. Health Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1136\/jmedgenet-2021-108301","article-title":"Neurofibromatosis type 1 families with first-degree relatives harbouring distinct NF1 pathogenic variants. Genetic counselling and familial diagnosis: what should be offered?","volume":"59","author":"Garcia","year":"2022","journal-title":"J. Med. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"T187","DOI":"10.1016\/j.ad.2022.10.043","article-title":"[Translated article] neurofibromatosis type 1: diagnostic timelines in children","volume":"114","author":"Garc\u00eda-Mart\u00ednez","year":"2023","journal-title":"Actas Dermosifiliogr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/ijerph18073724","article-title":"The role of parent\/caregiver with children affected by rare diseases: navigating between love and fear","volume":"18","author":"G\u00f3mez-Z\u00fa\u00f1iga","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1997","DOI":"10.1002\/jgc4.1997","article-title":"Reproductive decision-making experiences of Australian adults with neurofibromatosis type 1 and schwannomatosis","volume":"34","author":"Gonzalez","year":"2024","journal-title":"J. Genet. Couns."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s10072-021-05361-5","article-title":"Epidemiological and clinical burden associated with plexiform neurofibromas in pediatric neurofibromatosis type-1 (NF-1): a systematic literature review","volume":"43","author":"Iheanacho","year":"2022","journal-title":"Neurol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/gim.2017.215","article-title":"Prevalence of neurofibromatosis type 1 in the Finnish population","volume":"20","author":"Kallionp\u00e4\u00e4","year":"2018","journal-title":"Genet. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5114\/wo.2020.97637","article-title":"Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland","volume":"24","author":"Karwacki","year":"2020","journal-title":"Contemp. Oncol. Pozn."},{"key":"B37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5603\/njo.103614","article-title":"Coordinated medical care program for neurofibromatosis type 1 children and youth in Poland influences the future of their affected parents as well \u2014 a single academic reference center experience and national program description","volume":"75","author":"Karwacki","year":"2025","journal-title":"Nowotwory. J. Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.5114\/aoms.2019.85143","article-title":"Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in Poland","volume":"17","author":"Karwacki","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0310501","DOI":"10.1371\/journal.pone.0310501","article-title":"Altered body as a source of interactional problems in the family of individuals with neurofibromatosis type 1 - a polish study","volume":"19","author":"Kowal","year":"2024","journal-title":"PLoS One"},{"key":"B71","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s13023-025-04061-z","article-title":"\u201cTo have children or not?\u201d Between desire, responsibility, luck, and guilt: reproductive decision-making in individuals with neurofibromatosis type 1","volume":"20","author":"Kowal","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/jnen\/59.9.759","article-title":"Loss of neurofibromin is associated with activation of RAS\/MAPK and PI3-K\/AKT signaling in a neurofibromatosis 1 astrocytoma","volume":"59","author":"Lau","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13023-023-02911-2","article-title":"Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis","volume":"18","author":"Lee","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00381-020-04771-8","article-title":"Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism","volume":"36","author":"Legius","year":"2020","journal-title":"Childs Nerv. Syst."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12913-018-3471-5","article-title":"Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis","volume":"18","author":"Merker","year":"2018","journal-title":"BMC Health Serv. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13023-025-03677-5","article-title":"Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey","volume":"20","author":"Merker","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cfs.12246","article-title":"Adult children of parents with mental illness: navigating stigma","volume":"22","author":"Murphy","year":"2017","journal-title":"Child & Fam. Soc. Work"},{"key":"B47","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s11912-024-01527-4","article-title":"Past, present, and future therapeutic strategies for NF-1-Associated tumors","volume":"26","author":"Na","year":"2024","journal-title":"Curr. Oncol. Rep."},{"key":"B48","first-page":"575","article-title":"National institutes of health consensus development conference","volume":"45","year":"1988","journal-title":"Arch. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ajmg.a.35840","article-title":"Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge","author":"Oates","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"B50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1471-2296-10-68","article-title":"Explanation and relations. How do general practitioners deal with patients with persistent medically unexplained symptoms: a focus group study","volume":"10","author":"olde Hartman","year":"2009","journal-title":"BMC Fam. Pract."},{"key":"B51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1073858407309995","article-title":"Unawareness of illness in neuropsychiatric disorders: phenomenological certainty versus etiopathogenic vagueness","volume":"14","author":"Orfei","year":"2008","journal-title":"Neuroscientist"},{"key":"B52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13023-024-03319-2","article-title":"Time to diagnosis for a rare disease: managing medical uncertainty. A qualitative study","volume":"19","author":"Phillips","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","article-title":"Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation","volume":"24","author":"Plotkin","year":"2022","journal-title":"Genet. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13023-019-1285-0","article-title":"Education and information needs for physicians about rare diseases in Spain","volume":"15","author":"Ramalle-G\u00f3mara","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"B55","first-page":"131","article-title":"Neurofibromatosis: a neoplastic birth defect with two age peaks of severe problems","volume":"13","author":"Riccardi","year":"1977","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/ajmg.a.38680","article-title":"Worries and needs of adults and parents of adults with neurofibromatosis type 1","volume":"176","author":"Rietman","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"B57","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5603\/NJO.2022.0018","article-title":"Recommendations of the Polish Sarcoma group on diagnostic-therapeutic procedures and control in patients with type 1 neurofibromatosis (NF1) and the associated malignant neoplasm of peripheral nerve sheaths","volume":"72","author":"Rutkowski","year":"2022","journal-title":"Nowotwory. J. Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.socscimed.2018.10.012","article-title":"Depression in a depressed area: deservingness, mental illness, and treatment in the contemporary rural U.S","volume":"219","author":"Snell-Rood","year":"2018","journal-title":"Soc. Sci. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"100223","DOI":"10.1016\/j.esmoop.2021.100223","article-title":"Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review","volume":"6","author":"Solares","year":"2021","journal-title":"ESMO Open"},{"key":"B60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/17407745231207970","article-title":"Gene-targeted therapy for neurofibromatosis and schwannomatosis: the path to clinical trials","volume":"21","author":"Staedtke","year":"2024","journal-title":"Clin. Trials"},{"key":"B61","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.3390\/ijms22115850","article-title":"Current understanding of neurofibromatosis type 1, 2, and schwannomatosis","volume":"22","author":"Tamura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s12519-022-00675-6","article-title":"Australian children living with rare diseases: health service use and barriers to accessing care","volume":"19","author":"Teutsch","year":"2023","journal-title":"World J. Pediatr."},{"key":"B63","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int. J. Qual. Health Care"},{"key":"B64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13023-019-1075-8","article-title":"Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium","volume":"14","author":"Vandeborne","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s13023-021-02023-9","article-title":"Are rare diseases overlooked by medical education? Awareness of rare diseases among physicians in Poland: an explanatory study","volume":"16","author":"Walkowiak","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"872648","DOI":"10.3389\/fpubh.2022.872648","article-title":"The awareness of rare diseases among medical students and practicing physicians in the Republic of Kazakhstan. An exploratory study","volume":"10","author":"Walkowiak","year":"2022","journal-title":"Front. Public Health"},{"key":"B67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s13023-021-02127-2","article-title":"Rare pediatric diseases and pathways to psychosocial care: a qualitative interview study with professional experts working with affected families in Germany","volume":"16","author":"Witt","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"B68","first-page":"107","article-title":"Guzy twarzoczaszki jako wskazanie do transplantacji twarzy","volume-title":"Transplantacje ko\u0144czyny g\u00f3rnej i twarzy","author":"Wojtkiewicz","year":"2018"},{"key":"B69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13023-022-02243-7","article-title":"Physicians\u2019 knowledge on specific rare diseases and its associated factors: a national cross-sectional study from China","volume":"17","author":"Zhang","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13023-017-0622-4","article-title":"Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays","volume":"12","author":"Zurynski","year":"2017","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1713304\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T22:10:17Z","timestamp":1767737417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1713304\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":71,"alternative-id":["10.3389\/fgene.2025.1713304"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1713304","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"1713304"}}